Merz Neurosciences Announces Positive Phase III Results of Xeomin® (IncobotulinumtoxinA) for …

RALEIGH, N.C.–(BUSINESS WIRE)–Merz Neurosciences, a division of Merz North America, announced today positive topline results from its pivotal …

Link to Full Article

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!